Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03340142 · ClinicalTrials.gov registry record · NA

VIVO™ Accuracy Study

A NA study of Ventricular Tachycardia and Premature Ventricular Contraction, sponsored by Catheter Precision..

Completed
Registry status
NA
Development phase
45
Enrollment target
3
Study locations

NCT03340142 is a NA study of Ventricular Tachycardia and Premature Ventricular Contraction that has completed, run by Catheter Precision.. The registered enrollment target is 45 participants, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (84% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03340142, a NA study of Ventricular Tachycardia and Premature Ventricular Contraction, has completed, sponsored by Catheter Precision..

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
3
Study locations

Study Summary

A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.

Interventions

  • DEVICE VIVO™

Study Locations (3)

Iowa

  • University of Iowa - Iowa City

Maryland

  • Johns Hopkins Unveristy - Baltimore

South Carolina

  • Medical Unversity of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2018-01-29
Est. Completion 2018-11-01
Phase NA

Sponsor

Catheter Precision.

1 total trials

What the Registry Record Tells You About NCT03340142

The ClinicalTrials.gov registry entry for NCT03340142 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (84% lower). The listed sponsor is Catheter Precision., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which VIVO™ is the first listed.

NCT03340142 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Iowa, Maryland, South Carolina.

Frequently Asked Questions

What is clinical trial NCT03340142 about?

NCT03340142 is a clinical study titled "VIVO™ Accuracy Study". A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.

What is the current status of trial NCT03340142?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2018-01-29. Estimated completion is 2018-11-01.

What conditions does trial NCT03340142 study?

This clinical trial studies the following conditions: Ventricular Tachycardia, Premature Ventricular Contraction.

What interventions are being tested in trial NCT03340142?

The interventions under investigation include: VIVO™ (DEVICE).

Who is sponsoring clinical trial NCT03340142?

This trial is sponsored by Catheter Precision., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03340142 being conducted?

This trial has 3 study locations across Iowa, Maryland, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.